Status:
COMPLETED
The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Comparing standard treatment versus optimized antiplatelet therapy and outcomes measures.
Detailed Description
The study is aimed to evaluate if optimized antiplatelet treatment using a test and treat algorithm (with whole blood aggregometry) is able to improve clinical outcome of patients compared to standard...
Eligibility Criteria
Inclusion
- coronary stent implantation
Exclusion
- no consent
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01796691
Start Date
January 1 2009
End Date
February 1 2013
Last Update
February 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Center, Ruhr-University Bochum
Bochum, North Rhine-Westphalia, Germany, D-44791